Home  >  Products  >  FHL3 (four and a half LIM domains 3) Blocking Peptide (100ug)
FHL3 (four and a half LIM domains 3) Blocking Peptide (100ug)

FHL3 (four and a half LIM domains 3) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-FHL3 antibody (Catalogue #: ARP50498_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP50498
Size: 100 ug
Weight: 31kDa
Gene: 2275
Format: Lyophilized powder
Target: FHL3 contains 4 LIM zinc-binding domains. It is expressed only in skeletal muscle. FHL3 association with MyoD may contribute to the regulation of MyoD-dependent transcription of muscle genes and thereby myogenesis.LIM proteins are defined by the possession of a highly conserved double zinc finger motif called the LIM domain.[supplied by OMIM]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative names: MGC19547; MGC23614; MGC8696; SLIM2
See Full Product Listings >